Keros Therapeutics, Inc. (KROS)

Typically moves ±5.21% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE

Keros Therapeutics, Inc. (KROS) has a 22-report earnings history dating back to May 06, 2021. Its average absolute post-earnings move is ±5.21%, and 40.9% of those reactions were positive. Its largest post-earnings gain was +27.69% (Nov 04, 2021) and its largest decline was -14.96% (Mar 04, 2026). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How KROS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.21%

Positive %

40.9%

Negative %

59.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 03, 2026	☽ POST	+1.68%	open_in_new
May 14, 2026	☀ PRE	-8.5%	open_in_new
Mar 04, 2026	☽ POST	-14.96%	open_in_new
Nov 05, 2025	☽ POST	+3.32%	open_in_new
Aug 06, 2025	☽ POST	-7.29%	open_in_new
May 06, 2025	☽ POST	-0.36%	open_in_new
Feb 26, 2025	☽ POST	+0.64%	open_in_new
Nov 06, 2024	☽ POST	+1.08%	open_in_new
Aug 07, 2024	☽ POST	-2.18%	open_in_new
May 08, 2024	☀ PRE	-0.75%	open_in_new
Feb 28, 2024	☽ POST	-0.84%	open_in_new
Nov 06, 2023	☀ PRE	-0.78%	open_in_new
Aug 07, 2023	☀ PRE	-1.73%	open_in_new
May 04, 2023	☽ POST	-3.08%	open_in_new
Mar 03, 2023	☽ POST	-12%	open_in_new
Nov 03, 2022	☀ PRE	+1.69%	open_in_new
Aug 04, 2022	☽ POST	+12.77%	open_in_new
May 05, 2022	☀ PRE	-7.22%	open_in_new
Mar 09, 2022	☽ POST	+0.85%	open_in_new
Nov 04, 2021	☀ PRE	+27.69%	open_in_new
Aug 05, 2021	☽ POST	+2.83%	open_in_new
May 06, 2021	☽ POST	-2.28%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.21%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 21 →

Funds holding

$55634889

Total value held

Buying

11 added · 9 reduced

Blackrock, Inc.

$29898120 +15.86%

Federated Hermes, Inc.

$7494569 NEW BUY

State Street Corp

$5790765 -3.66%

Goldman Sachs Group Inc

$1902953 -20.77%

Wells Fargo & Company/Mn

$1663636 +2.94%

SEC Filing Types

description SCHEDULE 13G

10 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260908	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
4	20260820	open_in_new SEC.gov
4	20260819	open_in_new SEC.gov
144	20260818	open_in_new SEC.gov
3	20260813	open_in_new SEC.gov
10-Q	20260803	open_in_new SEC.gov
8-K	20260803	open_in_new SEC.gov

Frequently asked about KROS earnings

When does Keros Therapeutics, Inc. report earnings next? expand_more

Keros Therapeutics, Inc. (KROS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does KROS stock move after earnings? expand_more

Over 22 reports, KROS has moved an average of ±5.21% the session after earnings, closing higher 40.9% of the time.

What was KROS's biggest post-earnings move? expand_more

KROS's largest post-earnings gain on record was +27.69% on Nov 04, 2021, and its largest decline was -14.96% on Mar 04, 2026.

Where can I find Keros Therapeutics, Inc.'s SEC filings? expand_more

All of Keros Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.